HealthLynked (HLYK) Gains from Sales and Divestitures (2021 - 2022)

HealthLynked (HLYK) reported Gains from Sales and Divestitures of $354782.0 for Q3 2022, down 67.0% year-over-year from $1.1 million in Q3 2021, and down 67.0% quarter-over-quarter from $1.1 million in Q3 2021.

HealthLynked (HLYK) Gains from Sales and Divestitures (2021 - 2022) Analysis & Trends

HealthLynked (HLYK) has 2 years of Gains from Sales and Divestitures data on file, last reported at $354782.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn
10 HealthLynked - - 323,646.00

Historic Data

Download Data
DateValue
Sep 30, 2022 354,782.00
Sep 30, 2022 354,782.00
Sep 30, 2021 1.08 Mn
Sep 30, 2021 1.08 Mn